| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Nutritional Carcinogenesis [B. S. R., C. V. R.] and Division of Pathology and Toxicology [A. R.], American Health Foundation, Valhalla, New York 10595, and Chemoprevention Branch, Division of Cancer Control and Prevention, National Cancer Institute, Bethesda, Maryland 20892 [G. K.]
It has been reported that several naturally occurring and related synthetic organosulfur compounds exert chemopreventive effects in several target organs in rodent models. The chemopreventive actions of 40 and 80% maximum tolerated doses (MTD) of organosulfur compounds, namely anethole trithione, diallyl disulfide, N-acetylcysteine, and taurine, administered in AIN-76A diet, on azoxymethane (AOM)-induced neoplasia were investigated in male F344 rats. Also, the effects of these agents on the activities of phase II enzymes, namely glutathione S-transferase (GST), NAD(P)H-dependent quinone reductase, and UDP-glucuronosyl transferase, in the liver and colonic mucosa and tumors were assessed. The MTD levels of anethole trithione, diallyl disulfide, N-acetylcysteine, and taurine were determined in male F344 rats and found to be 250, 250, 1500, and 1500 ppm, respectively. At 5 weeks of age, animals were fed the control diet (AIN-76A) or experimental diets containing 40 or 80% MTD levels of each test agent. All animals in each group, except those allotted for vehicle (saline) treatment, were administered AOM s.c. at a dose rate of 15 mg/kg body weight once weekly for 2 weeks. All animals were necropsied during week 52 after the second AOM injection. Colonic mucosal and tumor and liver enzyme activities were measured in animals fed 80% MTD levels of each test agent. Colon tumors were subjected to histopathological evaluation and classified as invasive or noninvasive adenocarcinomas. Colon tumor incidence (percentage of animals with tumors) and tumor multiplicity (tumors/animal) were compared among various dietary groups. The results indicated that administration of 200 ppm (80% MTD) anethole trithione significantly inhibited the incidence and multiplicity of both invasive and noninvasive adenocarcinomas, whereas feeding of 100 ppm (40% MTD) anethole trithione or 100 (40% MTD) or 200 ppm (80% MTD) diallyl disulfide suppressed only invasive adenocarcinomas of the colon. Although diets containing N-acetylcysteine and taurine inhibited colon tumor multiplicity, the effect was somewhat marginal. GST, NAD-(P)H-dependent quinone reductase, and UDP-glucuronosyl transferase activities in colonic mucosa and tumor and liver were significantly elevated in animals fed anethole trithione or diallyl disulfide, compared to those fed the control diet. N-Acetylcysteine and taurine slightly but significantly increased only the GST activity in the liver. Although other mechanisms are not excluded, inhibition of AOM-induced colon carcinogenesis by anethole trithione and diallyl disulfide may be associated, in part, with increased activities of phase II enzymes such as GST, NAD(P)H-dependent quinone reductase, and UDP-glucuronosyl transferase in the liver and colon.
1 Supported by USPHS Contract NOI-CN-85095-05 and Grant CA-17613 from the National Cancer Institute.
2 To whom requests for reprints should be addressed, at Division of Nutritional Carcinogenesis, American Health Foundation, One Dana Road, Valhalla, NY 10595.
Received 1/28/93. Accepted 5/26/93.
This article has been cited by other articles:
![]() |
Y.-A. Kim, D. Xiao, H. Xiao, A. A. Powolny, K. L. Lew, M. L. Reilly, Y. Zeng, Z. Wang, and S. V. Singh Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak Mol. Cancer Ther., May 1, 2007; 6(5): 1599 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Herman-Antosiewicz, S. D. Stan, E.-R. Hahm, D. Xiao, and S. V. Singh Activation of a novel ataxia-telangiectasia mutated and Rad3 related/checkpoint kinase 1-dependent prometaphase checkpoint in cancer cells by diallyl trisulfide, a promising cancer chemopreventive constituent of processed garlic Mol. Cancer Ther., April 1, 2007; 6(4): 1249 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao, K. L. Lew, Y.-A. Kim, Y. Zeng, E.-R. Hahm, R. Dhir, and S. V. Singh Diallyl Trisulfide Suppresses Growth of PC-3 Human Prostate Cancer Xenograft In vivo in Association with Bax and Bak Induction. Clin. Cancer Res., November 15, 2006; 12(22): 6836 - 6843. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Antosiewicz, A. Herman-Antosiewicz, S. W. Marynowski, and S. V. Singh c-Jun NH2-Terminal Kinase Signaling Axis Regulates Diallyl Trisulfide-Induced Generation of Reactive Oxygen Species and Cell Cycle Arrest in Human Prostate Cancer Cells. Cancer Res., May 15, 2006; 66(10): 5379 - 5386. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xiao and S. V. Singh Diallyl trisulfide, a constituent of processed garlic, inactivates Akt to trigger mitochondrial translocation of BAD and caspase-mediated apoptosis in human prostate cancer cells Carcinogenesis, March 1, 2006; 27(3): 533 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katsuki, K. Hirata, H. Ishikawa, N. Matsuura, S.-i. Sumi, and H. Itoh Aged Garlic Extract Has Chemopreventative Effects On 1,2-Dimethylhydrazine-Induced Colon Tumors in Rats J. Nutr., March 1, 2006; 136(3): 847S - 851S. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Tsai, J.-J. Yang, H.-W. Chen, L.-Y. Sheen, and C.-K. Lii Garlic Organosulfur Compounds Upregulate the Expression of the {pi} Class of Glutathione S-Transferase in Rat Primary Hepatocytes J. Nutr., November 1, 2005; 135(11): 2560 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Herman-Antosiewicz and S. V. Singh Checkpoint Kinase 1 Regulates Diallyl Trisulfide-induced Mitotic Arrest in Human Prostate Cancer Cells J. Biol. Chem., August 5, 2005; 280(31): 28519 - 28528. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang and G. B. Gordon A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway Mol. Cancer Ther., July 1, 2004; 3(7): 885 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Druesne, A. Pagniez, C. Mayeur, M. Thomas, C. Cherbuy, P.-H. Duee, P. Martel, and C. Chaumontet Diallyl disulfide (DADS) increases histone acetylation and p21waf1/cip1 expression in human colon tumor cell lines Carcinogenesis, July 1, 2004; 25(7): 1227 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Huard, N. Druesne, D. Guyonnet, M. Thomas, A. Pagniez, A.-M. Le Bon, P. Martel, and C. Chaumontet Diallyl disulfide (DADS) enhances gap-junctional intercellular communication by both direct and indirect mechanisms in rat liver cells Carcinogenesis, January 1, 2004; 25(1): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Knowles and J. A. Milner Diallyl Disulfide Induces ERK Phosphorylation and Alters Gene Expression Profiles in Human Colon Tumor Cells J. Nutr., September 1, 2003; 133(9): 2901 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bose, J. Guo, L. Zimniak, S. K. Srivastava, S. P. Singh, P. Zimniak, and S. V. Singh Critical role of allyl groups and disulfide chain in induction of Pi class glutathione transferase in mouse tissues in vivo by diallyl disulfide, a naturally occurring chemopreventive agent in garlic Carcinogenesis, October 1, 2002; 23(10): 1661 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lam, C. MacAulay, J. C. le Riche, Y. Dyachkova, A. Coldman, M. Guillaud, E. Hawk, M.-O. Christen, and A. F. Gazdar A Randomized Phase IIb Trial of Anethole Dithiolethione in Smokers with Bronchial Dysplasia J Natl Cancer Inst, July 3, 2002; 94(13): 1001 - 1009. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Seril, J. Liao, K.-L. K. Ho, C. S. Yang, and G.-Y. Yang Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine Carcinogenesis, June 1, 2002; 23(6): 993 - 1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, J.-R. Ciu, Y. Ye, J.-M. Min, L.-H. Zhang, K. Wang, M. Gares, J. Cros, M. Wright, and J. Leung-Tack Antitumor activity of Z-ajoene, a natural compound purified from garlic: antimitotic and microtubule-interaction properties Carcinogenesis, April 1, 2002; 23(4): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Robert, B. Mouille, C. Mayeur, M. Michaud, and F. Blachier Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: evidence of sensitive and resistant sub-populations Carcinogenesis, August 1, 2001; 22(8): 1155 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Fleischauer and L. Arab Garlic and Cancer: A Critical Review of the Epidemiologic Literature J. Nutr., March 1, 2001; 131(3): 1032S - 1040. [Abstract] [Full Text] |
||||
![]() |
S. V. Singh Impact of Garlic Organosulfides on p21H-ras Processing J. Nutr., March 1, 2001; 131(3): 1046S - 1048. [Abstract] [Full Text] |
||||
![]() |
K. Song and J. A. Milner The Influence of Heating on the Anticancer Properties of Garlic J. Nutr., March 1, 2001; 131(3): 1054S - 1057. [Abstract] [Full Text] |
||||
![]() |
B. S. Reddy Novel Approaches to the Prevention of Colon Cancer by Nutritional Manipulation and Chemoprevention Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 239 - 247. [Abstract] [Full Text] |
||||
![]() |
C. Teyssier, L. Guenot, M. Suschetet, and M.-H. Siess Metabolism of Diallyl Disulfide by Human Liver Microsomal Cytochromes P-450 and Flavin-Containing Monooxygenases Drug Metab. Dispos., July 1, 1999; 27(7): 835 - 841. [Abstract] [Full Text] |
||||
![]() |
P. A. Münzel, S. Schmohl, H. Heel, K. Kälberer, B. S. Bock-Hennig, and K. W. Bock Induction of Human UDP Glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-Butylhydroquinone and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Caco-2 Cells Drug Metab. Dispos., May 1, 1999; 27(5): 569 - 573. [Abstract] [Full Text] |
||||
![]() |
K. Song and J. A. Milner Heating Garlic Inhibits Its Ability to Suppress 7,12-Dimethylbenz(a)anthracene-Induced DNA Adduct Formation in Rat Mammary Tissue J. Nutr., March 1, 1999; 129(3): 657 - 661. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |